Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Trem2 Agonism: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| Aβ clearance | activates | mechanism | 0.90 |
| amyloid-associated neurotoxicity | protective_against | phenotype | 0.90 |
| amyloid clearance | activates | process | 0.90 |
| microglial protective phenotype | activates | process | 0.70 |
| microglial phagocytosis | activates | mechanism | 0.70 |
| phagocytosis of synaptic material | enhances | process | 0.70 |
| early Alzheimer's disease | therapeutic_target_for | disease | 0.70 |
| Aβ clearance | enhances | phenotype | 0.70 |
| synaptic material phagocytosis | activates | phenotype | 0.70 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| amyloid-associated neurotoxicity | prevents | mechanism | 0.70 |
| microglial lipid metabolism | activates | process | 0.70 |
| amyloid clearance | causes | process | 0.70 |
| amyloid_clearance | enhances | phenotype | 0.70 |
| tau pathology | therapeutic_target_for | mechanism | 0.70 |
| microglial exhaustion | causes | phenotype | 0.70 |
| microglial activation | activates | process | 0.70 |
| cytokine release | causes | phenotype | 0.70 |
| microglial proliferation | activates | process | 0.70 |
| TYROBP pathway | modulates | pathway | 0.70 |
| cerebral amyloid angiopathy | causes | phenotype | 0.70 |
| neurodegeneration | protective_against | phenotype | 0.70 |
| amyloid burden | prevents | phenotype | 0.70 |
| microglial clustering around plaques | enhances | phenotype | 0.70 |
| neurodegeneration | therapeutic_target_for | disease | 0.70 |
| Cytokine Release | increases_risk | phenotype | 0.70 |
| microglial phenotype shift | causes | mechanism | 0.70 |
| synaptic material phagocytosis | enhances | phenotype | 0.70 |
| DAM1 to homeostatic state reversion | causes | mechanism | 0.70 |
| DAM1 to homeostatic microglia | modulates | cell_type | 0.70 |
| Microglial Phagocytosis | activates | phenotype | 0.50 |
| myelin preservation | prevents | phenotype | 0.50 |
| Alzheimer's disease | therapeutic_target_for | disease | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-27 | 7 hypotheses Top: 0.710
neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861
neurodegeneration | 2026-04-18 | 7 hypotheses Top: 0.105
neurodegeneration | 2026-04-17 | 0 hypotheses
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.627
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| E2F coordination of G2/M transcriptional program | exploratory | 0.750 | 0.00 | endocycling mammalian cells | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 1 |
| The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] | Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei | Neuron | 2026 | 0 |
| Role of TREM2 in neuroinflammation. [PMID:41213496] | Abdulkhaliq AA, Alasiri G, Almoghrabi Y, | Exp Neurol | 2026 | 0 |
| Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] | Zhang J, St Pierre Schneider B, Muguerza | Am J Physiol Endocrinol Metab | 2026 | 0 |
| Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvir [PMID:41576929] | Mateus-Tique J, Lakshmi A, Singh B, Iyer | Cancer Cell | 2026 | 0 |
| Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] | Li X, Tang X, Zeng J, Duan L, Hou Z et a | Cell | 2026 | 0 |
| TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] | Feiten AF, Dahm K, Schlepckow K, van Len | Nat Commun | 2026 | 0 |
| Large-scale single-cell analysis and in silico perturbation reveal dynamic evolu [PMID:41617928] | Xia P, Shuang S, Fu D, Liu L, Yang D et | NPJ Precis Oncol | 2026 | 0 |
| Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant [PMID:41720086] | Zhao Q, Huang R, Wang C, Hu J, Nie R et | Cancer Cell | 2026 | 0 |
| TREM2 in neurodegeneration and diseases. [PMID:41792456] | ["Abdulkhaliq A", "Alasiri G", "Kim B", | Molecular psychiatry | 2026 | 0 |
| Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] | Aranda-Abreu GE, Rojas-Durán F, Hernánde | Neurology international | 2026 | 0 |
| Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842] | Alhusaini M, Mussa BM, Ilce BY, Alhaj H, | Frontiers in aging neuroscienc | 2026 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Viral and non-viral cellular therapies for neurodegeneration. [PMID:41585268] | ["Srivastav Jyotsna", "Sharma Sachin"] | Frontiers in medicine | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurod [PMID:33603230] | Dong Y, D'Mello C, Pinsky W, Lozinski BM | Nature neuroscience | 2021 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.77 · 2026-04-28
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 4 · Score: 0.46 · 2026-04-27
closed · Rounds: 4 · Score: 0.50 · 2026-04-27
closed · Rounds: 4 · Score: 0.50 · 2026-04-27
closed · Rounds: 4 · Score: 0.49 · 2026-04-27
closed · Rounds: 4 · Score: 0.81 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.64 · 2026-04-26
Hypotheses and analyses mentioning Trem2 Agonism in their description or question text
Score: 0.644 · neurodegeneration · 2026-04-14
## Mechanistic Overview H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to Amyloid Clearance
Score: 0.637 · Alzheimer's disease · 2026-04-04
## Mechanistic Overview Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in Early Amyloid Phase starts from the
Score: 0.620 · neurodegeneration · 2026-04-13
## Mechanistic Overview TREM2 Agonism to Reprogram Infiltrated Monocytes Toward Neuroprotective Phenotype starts from th
Score: 0.521 · neurodegeneration · 2026-04-14
## Mechanistic Overview TREM2 Agonism to Redirect Microglia from Synaptic Pruning to OPTN-Deficient Neuron Protection st
Score: 0.105 · neurodegeneration · 2026-04-18
## Mechanistic Overview TREM2 Agonism with CX3CR1 Antagonism for Microglial Homeostasis starts from the claim that modul